
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.

An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.

Incoming from the big man in red...

"It is Christmas eve and our patient lies on the table in twilight sleep..."

Carmen Kosicek, MSN, PMHNP-BC, and Charles Montano, MD, comment on the interplay between depression and other comorbid psychiatric and medical health conditions as well as the economic impact of MDD.

Charles Montano, MD; Carmen Kosicek, MSN, PMHNP-BC; and Gus Alva, MD, DFAPA, review the impact of the duration of MDD episodes and goals of managing episode recurrences.

When you speak against one form of hate, you speak against all hate...

How can you decrease financial stress around the holidays?

How can we support the unique needs of this patient population?

What is most memorable about your childhood holiday celebrations?

New research explores ulotaront as an adjunctive therapy for adults with major depressive disorder.

How can listening to music help promote mental health?

"We wait, our bare feet dangling in the horse trough..."

Most men want more friends—and it's affecting their mental health. How can clinicians help?

"My work is loving the world..."

How can we better understand the evolving roles of men and boys in society?

In honor of Barry Marcus.

Clinicians are often busier than usual during the holidays. How can you find the time to spend quality time with your loved ones?

Drs Paul Doghramji and Leslie Citrome share approaches to communicate with patients and increase awareness of insomnia disorder

Leslie Citrome, MD, MPH, comments on long-term data for daridorexant, suvorexant, and lemborexant.

"Love is apart from all things. Desire and excitement are nothing beside it."

What's important about gratitude?

Experts discuss daridorexant efficacy and safety data, and dosing considerations and what to communicate with patients when using daridorexant for insomnia.

Drs Paul Doghramji and Leslie Citrome provide an overview of dual orexin receptor antagonists (DORAs), suvorexant, lemborexant, and daridorexant, in treatment of insomnia disorder.

"For no particular reason I lift my dusty volume of Freud’s Standard Edition from a shelf..."

Are you ready to be CHEERFUL this year?

Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?

Experts in attention-deficit/hyperactivity disorder discuss future nonmedication interventions, like trigeminal nerve stimulation and digital therapeutics.

Theresa Cerulli, MD, discusses the practical considerations for using serdexmethylphenidate-dexmethylphenidate for the treatment of attention-deficit/hyperactivity disorder.

Drs Paul Doghramji and Leslie Citrome discuss the sleep and wakefulness signals and pathways that contribute to insomnia.

Drs Paul Doghramji and Leslie Citrome review the use of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) to assess treatment efficacy.